603882 金域医学
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.199-4.8607.57136.88543.992
总资产报酬率 ROA (%)-0.841-3.4415.01522.35725.527
投入资产回报率 ROIC (%)-1.071-4.4246.97533.45238.736

边际利润分析
销售毛利率 (%)33.93333.14636.47843.12847.292
营业利润率 (%)-3.540-3.8018.89721.62823.250
息税前利润/营业总收入 (%)-3.748-6.1408.65721.37623.090
净利润/营业总收入 (%)-3.232-5.7687.45818.38319.790

收益指标分析
经营活动净收益/利润总额(%)-133.228-100.489122.168106.417101.367
价值变动净收益/利润总额(%)-1.83215.47535.522-0.325-0.266
营业外收支净额/利润总额(%)3.20237.707-2.631-0.798-1.063

偿债能力分析
流动比率 (X)3.0863.2783.0732.3272.127
速动比率 (X)2.9983.1892.9812.2392.035
资产负债率 (%)28.98228.06827.36536.10439.330
带息债务/全部投入资本 (%)9.2068.1214.9664.7477.664
股东权益/带息债务 (%)964.5201,105.7561,855.2511,940.6821,158.661
股东权益/负债合计 (%)240.687251.139259.693172.122149.086
利息保障倍数 (X)41.182159.115-701.395-263.228273.356

营运能力分析
应收账款周转天数 (天)255.475243.646260.537135.972110.923
存货周转天数 (天)17.68416.72221.68415.34616.678